Core-shell nanoparticles based on pullulan and poly(β-amino) ester for hepatoma-targeted codelivery of gene and chemotherapy agent

ACS Applied Materials and Interfaces

Volumn 6, Issue 21, 2014, Pages 18712-18720

  Liu, Yuanyuan ^a   Wang, Yan ^a   Zhang, Cong ^a   Zhou, Ping ^a   Liu, Yang ^a   An, Tong ^a   Sun, Duxin ^b   Zhang, Ning ^a   Wang, Yinsong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

chemotherapy agent; gene; hepatoma; poly( amino) ester; pullulan

Indexed keywords

BINDING ENERGY; CELL PROLIFERATION; CHEMOTHERAPY; ESTERS; GENES; MAMMALS; MOLECULAR BIOLOGY; NANOPARTICLES; SHELLS (STRUCTURES); TUMORS;

ASIALOGLYCOPROTEIN RECEPTORS; CHEMOTHERAPY AGENTS; CORE SHELL STRUCTURE; GREEN FLUORESCENT PROTEIN; HEPATOMA; METHOTREXATE (MTX); NANOPARTICLE SYSTEMS; PULLULANS;

CORE SHELL NANOPARTICLES;

ANTINEOPLASTIC AGENT; DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; GLUCAN; GREEN FLUORESCENT PROTEIN; METHOTREXATE; NANOPARTICLE; POLY(BETA-AMINO ESTER); POLYMER; PULLULAN;

ANIMAL; CHEMISTRY; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PARTICLE SIZE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DRUG CARRIERS; GLUCANS; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; METHOTREXATE; MICE; MICE, NUDE; NANOPARTICLES; PARTICLE SIZE; POLYMERS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84910135099     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am504203x     Document Type: Article

References (38)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Estimating the World Cancer Burden: Globocan 2000 Int. J. Cancer 2001, 94, 153-156
2. Altekruse, S. F.; McGlynn, K. A.; Reichman, M. E. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States from 1975 to 2005 J. Clin. Oncol. 2009, 27, 1485-1491
3. Lau, W.-Y; Lai, E. C. H. Hepatocellular Carcinoma: Current Management and Recent Advances Hepatobiliary Pancreatic Dis. Int. 2008, 7, 237-257
4. Blum, H. E. Hepatocellular Carcinoma: Therapy and Prevention World J. Gastroenterol. 2005, 11, 7391-7400
5. Cahill, B. A.; Braccia, D. Current Treatment for Hepatocellular Carcinoma Clin. J. Oncol. Nurs. 2004, 8, 393-399
6. Decadt, B.; Siriwardena, A. K. Radiofrequency Ablation of Liver Tumors: Systematic Review Lancet Oncol. 2004, 5, 550-560
7. Ishikawa, H.; Nakao, K.; Matsumoto, K.; Ichikawa, T.; Hamasaki, K.; Nakata, K.; Eguchi, K. Antiangiogenic Gene Therapy for Hepatocellular Carcinoma Using Angiostatin Gene Hepatology 2003, 37, 696-704
8. Hwang, L.-H. Gene Therapy Strategies for Hepatocellular Carcinoma J. Biomed. Sci. 2006, 13, 453-468
9. Hernández-Alcoceba, R.; Sangro, B.; Prieto, J. Gene Therapy of Liver Cancer Ann. Hepatol. 2007, 6, 5-14
10. McMenamin, M. M. Translational Benefits of Gene Therapy to Date Clin. Oncol. Cancer Res. 2011, 8, 10-15
11. Xu, Q.; Leong, J.; Chua, Q. Y.; Chi, Y. T.; Chow, P. K.; Pack, D. W.; Wang, C. H. Combined Modality Doxorubicin-Based Chemotherapy and Chitosan-Mediated p53 Gene Therapy Using Double-Walled Microspheres for Treatment of Human Hepatocellular Carcinoma Biomaterials 2013, 34, 5149-5162
12. Jacobs, F.; Gordts, S. C.; Muthuramu, I.; Geest, B. D. The Liver as a Target Organ for Gene Therapy: State of the Art, Challenges, and Future Perspectives Pharmaceuticals 2012, 5, 1372-1392
13. Thomas, C. E.; Ehrhardt, A.; Kay, M. A. Progress and Problems with the Use of Viral Vectors for Gene Therapy Nat. Rev. Genet. 2003, 4, 346-358
14. Kaufmann, K. B.; Büning, H.; Galy, A.; Schambach, A.; Grez, M. Gene Therapy on the Move EMBO Mol. Med. 2013, 5, 1642-1661
15. Niidome, T.; Huang, L. Gene Therapy Progress and Prospects: Nonviral Vectors Gene Ther. 2002, 9, 1647-1652
16. Zhang, Y.; Satterlee, A.; Huang, L. In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles? Mol. Ther. 2012, 20, 1298-1304
17. Ding, B.; Li, T.; Zhang, J.; Zhao, L.; Zhai, G. Advances in Liver-Directed Gene Therapy for Hepatocellular Carcinoma by Non-Viral Delivery Systems Curr. Gene Ther. 2012, 12, 92-102
18. Morille, M.; Passirani, C.; Vonarbourg, A.; Clavreul, A.; Benoit, J.-P. Progress in Developing Cationic Vectors for Non-Viral Systemic Gene Therapy against Cancer Biomaterials 2008, 29, 3477-3496
19. Canine, B. F.; Hatefi, A. Development of Recombinant Cationic Polymers for Gene Therapy Research Adv. Drug Delivery Rev. 2010, 62, 1524-1529
20. Ibraheem, D.; Elaissari, A.; Fessi, H. Gene Therapy and DNA Delivery Systems Int. J. Pharm. 2014, 459, 70-83
21. Anderson, D. G.; Peng, W.; Akinc, A.; Hossain, N.; Kohn, A.; Padera, R.; Langer, R.; Sawicki, J. A. A Polymer Library Approach to Suicide Gene Therapy for Cancer Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16028-16033
22. Green, J. J.; Chiu, E.; Leshchiner, E. S.; Shi, J.; Langer, R.; Anderson, D. G. Electrostatic Ligand Coatings of Nanoparticles Enable Ligand-Specific Gene Delivery to Human Primary Cells Nano Lett. 2007, 7, 874-879
23. Lee, J.-S.; Green, J. J.; Love, K. T.; Sunshine, J.; Langer, R.; Anderson, D. G. Gold, Poly(α-amino ester) Nanoparticles for Small Interfering RNA Delivery Nano Lett. 2009, 9, 2402-2406
24. Fields, R. J.; Cheng, C. J.; Quijano, E.; Weller, C.; Kristofik, N.; Duong, N.; Hoimes, C.; Egan, M. E.; Saltzman, W. M. Surface Modified Poly(β amino ester)-Containing Nanoparticles for Plasmid DNA Delivery J. Controlled Release 2012, 164, 41-48
25. Gu, J.; Wang, X.; Jiang, X.; Chen, Y.; Chen, L.; Fang, X.; Sha, X. Self-Assembled Carboxymethyl Poly(l -histidine) Coated Poly(β-amino ester)/DNA Complexes for Gene Transfection Biomaterials 2012, 33, 644-658
26. Leathers, T. D. Biotechnological Production and Applications of Pullulan Appl. Microbial. Biotechnol. 2003, 62, 468-473
27. Singha, R. S.; Sainia, G. K.; Kennedy, J. F. Pullulan: Microbial Sources, Production and Applications Carbohydr. Polym. 2008, 73, 515-531
28. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev. 2001, 53, 283-318
29. Kaneo, Y.; Tanaka, T.; Nakano, T.; Yamaguchi, Y. Evidence for Receptor-Mediated Hepatic Uptake of Pullulan in Rats J. Controlled Release 2001, 70, 365-373
30. Tang, H.-B.; Li, L.; Chen, H.; Zhou, Z.-M.; Chen, H.-L.; Li, X.-M.; Liu, L.-R.; Wang, Y.-S.; Zhang, Q.-Q. Stability and in Vivo Evaluation of Pullulan Acetate as a Drug Nanocarrier Drug Delivery 2010, 17, 552-558
31. Wang, Y.; Chen, H.; Liu, Y.; Wu, J.; Zhou, P.; Wang, Y.; Li, R.; Yang, X.; Zhang, N. pH-Sensitive Pullulan-Based Nanoparticle Carrier of Methotrexate and Combretastatin A4 for the Combination Therapy against Hepatocellular Carcinoma Biomaterials 2013, 34, 7181-7190
32. Hossain, M. A.; Kim, D. H.; Jang, J. Y.; Kang, Y. J.; Yoon, J.-H.; Moon, J.-O.; Chung, H. Y.; Kim, G.-Y.; Choi, Y. H.; Copple, B. L. Aspirin Induces Apoptosis in Vitro and Inhibits Tumor Growth of Human Hepatocellular Carcinoma Cells in a Nude Mouse Xenograft Model Int. J. Oncol. 2012, 40, 1298-1304
33. Davis, B. G.; Robinson, M. A. Drug Delivery Systems Based on Sugar-Macromolecule Conjugates Curr. Opin. Drug Discovery Dev. 2002, 5, 279-288
34. Medina, S. H.; Tekumalla, V.; Chevliakov, M. V.; Shewach, D. S.; Ensminger, W. D.; El-Sayed, M. E. H. N -Acetylgalactosamine-Functionalized Dendrimers as Hepatic Cancer Cell-Targeted Carriers Biomaterials 2011, 32, 4118-4129
35. Guo, R.; Yao, Y.; Cheng, G.; Wang, S. H.; Li, Y.; Shen, M.; Zhang, Y.; Baker, J. R.; Wang, J.; Shi, X. Synthesis of Glycoconjugated Poly(amindoamine) Dendrimers for Targeting Human Liver Cancer Cells RSC Adv. 2012, 2, 99-102
36. 111In-Labeled Lactosaminated Bovine Serum Albumin in Rats Pharm. Res. 1991, 8, 1253-1257
37. Grandinetti, G.; Smith, A. E.; Reineke, T. M. Membrane and Nuclear Permeabilization by Polymeric pDNA Vehicles: Efficient Method for Gene Delivery or Mechanism of Cytotoxicity? Mol. Pharmaceutics 2012, 9, 523-538
38. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In Vitro Cytotoxicity Testing of Polycations: Influence of Polymer Structure on Cell Viability and Hemolysis Biomaterials 2003, 24, 1121-1131